E-LIB Suche - Ergebnisse für: Petrylak, D.

1

Clinical outcomes of patients with metastatic Hormone-Sensi..:

Stenzl, A. ; Shore, N.D. ; Villers, A....
European Urology. 81 (2022) - p. S776-S777 , 2022

Link: https://doi.org/10.1016/..

2

ARCHES: Efficacy of androgen deprivation therapy (ADT) with..:

Stenzl, A. ; Szmulewitz, R.Z. ; Petrylak, D....
European Urology Open Science. 19 (2020) - p. e865-e866 , 2020

Link: https://doi.org/10.1016/..

3

A phase 3 study to evaluate enfortumab vedotin (EV) versus ..:

Petrylak, D. ; Rosenberg, J. ; Duran, I....
European Urology Supplements. 18 (2019) 1 - p. e1836-e1837 , 2019

Link: https://doi.org/10.1016/..

4

Phase 3 study of androgen deprivation therapy (ADT) with en..:

Basso, U. ; Galetti, T. Prayer ; Armstrong, A....
European Urology Supplements. 18 (2019) 9 - p. e3258 , 2019

Link: https://doi.org/10.1016/..

5

EV-201 Study: A single-arm, open-label, multicenter study o..:

Rosenberg, J. ; Balar, A. ; O'Donnell, P....
European Urology Supplements. 17 (2018) 2 - p. e1152 , 2018

Link: https://doi.org/10.1016/..

6

EV-103 Study: A phase 1b dose-escalation and dose-expansion..:

Hoimes, C.J. ; Petrylak, D. ; Flaig, T....
European Urology Supplements. 17 (2018) 2 - p. e1151 , 2018

Link: https://doi.org/10.1016/..

7

Healthcare resource utilization in RANGE: Ramucirumab plus ..:

Bamias, A. ; Van Der Heijden, M. ; De Wit, R....
European Urology Supplements. 17 (2018) 2 - p. e140-e141 , 2018

Link: https://doi.org/10.1016/..

8

Pembrolizumab vs investigator-choice chemotherapy for previ..:

Necchi, A. ; Bellmunt, J. ; De Wit, R....
European Journal of Cancer. 72 (2017) - p. S2 , 2017

Link: https://doi.org/10.1016/..

9

2637 Baseline circulating tumor cells (CTC) and serum heat ..:

Petrylak, D. ; Eigl, B. ; Senkus, E....
European Journal of Cancer. 51 (2015) - p. S525 , 2015

Link: https://doi.org/10.1016/..

10

21LBA Atezolizumab in patients (pts) with locally-advanced ..:

Rosenberg, J. ; Petrylak, D. ; Abidoye, O....
European Journal of Cancer. 51 (2015) - p. S720 , 2015

Link: https://doi.org/10.1016/..

11

2526 Immune responses and clinical data from STRIDE, a rand..:

Petrylak, D. ; Quinn, D. ; Dreicer, R....
European Journal of Cancer. 51 (2015) - p. S483 , 2015

Link: https://doi.org/10.1016/..

12

870 A phase 2 trial of prostate specific membrane antigen a..:

Petrylak, D. ; Smith, D.C. ; Appleman, L.J....
European Urology Supplements. 13 (2014) 1 - p. e870 , 2014

Link: https://doi.org/10.1016/..

13

Prognostic Model Predicting Metastatic Castration-Resistant..:

Halabi, S. ; Lin, C.-Y. ; Small, E. J....
JNCI Journal of the National Cancer Institute. 105 (2013) 22 - p. 1729-1737 , 2013

Link: https://doi.org/10.1093/..

14

244 Prostate Specific Membrane Antigen Antibody Drug Conjug..:

Petrylak, D. ; Kantoff, P. ; Mega, A....
European Journal of Cancer. 48 (2012) - p. 75 , 2012

Link: https://doi.org/10.1016/..

15

P114 Safety and efficacy of orteronel (TAK-700), an oral, i..:

Petrylak, D. ; Gandhi, J. ; Clark, W.R....
European Urology Supplements. 11 (2012) 5 - p. 230 , 2012

Link: https://doi.org/10.1016/..